Please use this identifier to cite or link to this item: https://doi.org/10.1161/01.RES.0000185327.45463.A8
DC FieldValue
dc.titleNovel role of lactosylceramide in vascular endothelial growth factor-mediated angiogenesis in human endothelial cells
dc.contributor.authorRajesh, M.
dc.contributor.authorKolmakova, A.
dc.contributor.authorChatterjee, S.
dc.date.accessioned2014-11-10T09:42:41Z
dc.date.available2014-11-10T09:42:41Z
dc.date.issued2005-10-14
dc.identifier.citationRajesh, M., Kolmakova, A., Chatterjee, S. (2005-10-14). Novel role of lactosylceramide in vascular endothelial growth factor-mediated angiogenesis in human endothelial cells. Circulation Research 97 (8) : 796-804. ScholarBank@NUS Repository. https://doi.org/10.1161/01.RES.0000185327.45463.A8
dc.identifier.issn00097330
dc.identifier.urihttp://scholarbank.nus.edu.sg/handle/10635/107736
dc.description.abstractVascular endothelial growth factor (VEGF) has been implicated in angiogenesis associated with coronary heart disease, vascular complications in diabetes, inflammatory vascular diseases, and tumor metastasis. The mechanism of VEGF-driven angiogenesis involving glycosphingolipids such as lactosylceramide (LacCer), however, is not known. To demonstrate the involvement of LacCer in VEGF-induced angiogenesis, we used small interfering RNA (siRNA)-mediated silencing of LacCer synthase expression (GalT-V) in human umbilical vein endothelial cells. This gene silencing markedly inhibited VEGF-induced platelet endothelial cell adhesion molecule-1 (PECAM-1) expression and angiogenesis. Second, we used D-threo-1-phenyl-2-decanoylamino-3-morpholino-1-propanol (D-PDMP), an inhibitor of LacCer synthase and glucosylceramide synthase, that significantly mitigated VEGF-induced PECAM-1 expression and angiogenesis. Interestingly, these phenotypic changes were reversed by LacCer but not by structurally related compounds such as glucosylceramide, digalactosylceramide, and ceramide. In a human mesothelioma cell line (REN) that lacks the endogenous expression of PECAM-1, VEGF/LacCer failed to stimulate PECAM-1 expression and tube formation/angiogenesis. In REN cells expressing human PECAM-1 gene/protein, however, both VEGF and LacCer-induced PECAM-1 protein expression and tube formation /angiogenesis. In fact, VEGF-induced but not LacCer-induced angiogenesis was mitigated by SU-1498, a VEGF receptor tyrosine kinase inhibitor. Also, VEGF/LacCer induced PECAM-1 expression and angiogenesis was mitigated by protein kinase C and phospholipase A 2 inhibitors. These results indicate that LacCer generated in VEGF-treated endothelial cells may serve as an important signaling molecule for PECAM-1 expression and in angiogenesis. This finding and the reagents developed in our report may be useful as anti-angiogenic drugs for further studies in vitro and in vivo. © 2005 American Heart Association, Inc.
dc.description.urihttp://libproxy1.nus.edu.sg/login?url=http://dx.doi.org/10.1161/01.RES.0000185327.45463.A8
dc.sourceScopus
dc.subjectAngiogenesis
dc.subjectLactosylceramide
dc.subjectPlatelet endothelial cell adhesion molecule-1
dc.subjectVascular endothelial growth factor
dc.typeArticle
dc.contributor.departmentBIOCHEMISTRY
dc.contributor.departmentBIOLOGICAL SCIENCES
dc.description.doi10.1161/01.RES.0000185327.45463.A8
dc.description.sourcetitleCirculation Research
dc.description.volume97
dc.description.issue8
dc.description.page796-804
dc.description.codenCIRUA
dc.identifier.isiut000232554000010
Appears in Collections:Staff Publications

Show simple item record
Files in This Item:
There are no files associated with this item.

SCOPUSTM   
Citations

50
checked on Aug 8, 2022

WEB OF SCIENCETM
Citations

46
checked on Aug 8, 2022

Page view(s)

150
checked on Aug 4, 2022

Google ScholarTM

Check

Altmetric


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.